LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_002691.4:c.2959del
POLD1
· NP_002682.2:p.(Asp987ThrfsTer58)
· NM_002691.4
GRCh37: chr19:50919865 AG>A
·
GRCh38: chr19:50416608 AG>A
Gene:
POLD1
Transcript:
NM_002691.4
Final call
Likely Pathogenic
PVS1 very strong
PM2 supporting
Variant details
Gene
POLD1
Transcript
NM_002691.4
Protein
NP_002682.2:p.(Asp987ThrfsTer58)
gnomAD AF
5.7738350325515986e-06 (v4.1)
ClinVar
Uncertain significance
OncoKB
Unknown Oncogenic Effect
Classification rationale
Interpretation summary
Generated evidence synthesis
1
PVS1 (Very Strong): frameshift p.(Asp987ThrfsTer58) introduces a premature stop 58 codons downstream, predicted to trigger nonsense-mediated decay.
2
PM2 (Supporting): overall allele frequency 5.77e-06 in gnomAD v4.1, far below the 0.1% threshold, with no homozygotes.
3
Overall: Likely Pathogenic — PVS1 (Very Strong) plus PM2 (Supporting) under the ClinGen SVI 2020 PM2-downgrade addendum (PVS1 + 1 supporting).
Final determination:
PVS1 (very strong) + PM2 (supporting) combine to Likely Pathogenic per the ClinGen SVI 2020 PM2-downgrade addendum.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | Met | Met (Very Strong): frameshift creates a premature stop codon 58 codons downstream, predicted to trigger nonsense-mediated decay. |
pvs1_gene_context
pvs1_variant_assessment
pvs1_generic_framework
clinvar
|
| PS1 | N/A | Not applicable: frameshift produces no altered amino acid, so there is no residue to compare against a previously established pathogenic change. |
generic_acmg_combination_rules
|
| PS2 | Not assessed | Not assessed: no parental testing or de novo confirmation for this variant was documented. |
|
| PS3 | Not assessed | Not assessed: no functional assay data for this exact variant was available. |
|
| PS4 | Not assessed | Not assessed: no case-control counts or qualifying case series for this exact variant were available. |
PMID:23263490
PMID:23447401
|
| PM1 | N/A | Not applicable: PM1 requires a missense variant; this frameshift leaves no altered residue to evaluate for hotspot membership. |
generic_acmg_combination_rules
|
| PM2 | Met | Met (Supporting): allele frequency 5.77e-06 in gnomAD v4.1, far below the 0.1% threshold. Flagged for human review: a ClinVar submitter noted gnomAD frequency data at this position may be unreliable. |
gnomad_v4
gnomad_v2
gnomad_canada
clinvar
|
| PM3 | N/A | Not applicable: POLD1 disease here is dominant, with no evidence of a recessive disorder requiring trans configuration. |
|
| PM4 | N/A | Not applicable: PM4 applies to in-frame indels or stop-loss changes; this frameshift causes no protein length change. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PM5 | N/A | Not applicable: PM5 requires a missense change at this residue; this frameshift creates no missense to compare. |
generic_acmg_combination_rules
|
| PM6 | Not assessed | Not assessed: no parental testing or clinical context supporting an assumed de novo occurrence was documented. |
|
| PP1 | Not assessed | Not assessed: no affected relatives, informative meioses, or segregation data for this variant were documented. |
|
| PP2 | N/A | Not applicable: PP2 applies only to missense variants; this frameshift involves no missense change. |
generic_acmg_combination_rules
|
| PP3 | N/A | Not applicable: PP3 concerns missense/synonymous splicing predictions; no in-silico scores apply to this frameshift. |
|
| PP4 | Not assessed | Not assessed: no patient-level phenotype or family-history data specific to this case was available. |
|
| PP5 | Not met | Not met: ClinVar variation 935838 has only two Uncertain-significance laboratory submissions and no expert-panel classification. |
clinvar
|
| BA1 | Not met | Not met: highest observed allele frequency 5.53e-05 is far below the 1% BA1 threshold. |
gnomad_v4
gnomad_v2
|
| BS1 | Not met | Not met: highest observed allele frequency 5.53e-05 is far below the 0.3% BS1 threshold. |
gnomad_v4
gnomad_v2
|
| BS2 | Not assessed | Not assessed: no phenotype-confirmed healthy-adult observation exists; zero homozygotes alone are insufficient. |
gnomad_v4
gnomad_v2
|
| BS3 | Not assessed | Not assessed: no functional assay data for this variant was available to demonstrate normal function. |
|
| BS4 | Not assessed | Not assessed: no tested relatives or non-segregation observations were documented for this variant. |
|
| BP1 | N/A | Not applicable: BP1 applies only to missense variants; this frameshift involves no missense change. |
generic_acmg_combination_rules
|
| BP2 | Not assessed | Not assessed: no data on phase with another variant (trans or cis) was available. |
|
| BP3 | N/A | Not applicable: BP3 concerns in-frame indels in repetitive regions; this frameshift does not qualify. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| BP4 | N/A | Not applicable: BP4 requires missense/synonymous in-silico scores; none apply to this frameshift. |
|
| BP5 | Not assessed | Not assessed: no alternative molecular cause for the patient's phenotype was documented. |
|
| BP6 | Not met | Not met: ClinVar variation 935838 has only two Uncertain-significance laboratory submissions and no expert-panel classification. |
clinvar
|
| BP7 | N/A | Not applicable: BP7 applies to synonymous variants; this frameshift alters the encoded protein sequence. |
generic_acmg_combination_rules
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.